Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;234(9):14489-14499.
doi: 10.1002/jcp.28252. Epub 2019 Feb 18.

Inflammatory cytokines in bladder cancer

Pejman Shadpour  1 , Mojtaba Zamani  2 , Nazi Aghaalikhani  3   4 , Nadereh Rashtchizadeh  3   4
Affiliations
Review

Inflammatory cytokines in bladder cancer

Pejman Shadpour et al. J Cell Physiol. 2019 Sep.

Abstract

The presence of inflammatory cells and their products in the tumor microenvironment plays a crucial role in the pathogenesis of a tumor. Releasing the cytokines from a host in response to infection and inflammation can inhibit tumor growth and progression. However, tumor cells can also respond to the host cytokines with increasing the growth/invasion/metastasis. Bladder cancer (BC) is one of the most common cancers in the world. The microenvironment of a bladder tumor has been indicated to be rich in growth factors/inflammatory cytokines that can induce the tumor growth/progression and also suppress the immune system. On the contrary, modulate of the cancer progression has been shown following upregulation of the cytokines-related pathways that suggested the cytokines as potential therapeutic targets. In this study, we provide a summary of cytokines that are involved in BC formation/regression with both inflammatory and anti-inflammatory properties. A more accurate understanding of tumor microenvironment creates favorable conditions for cytokines targeting to treat BC.

Keywords: bladder cancer; cytokines; inflammation; microenvironment; receptors.

PubMed Disclaimer

References

REFERENCES
    1. Abdel-Latif, M. M., Duggan, S., Reynolds, J. V., & Kelleher, D. (2009). Inflammation and esophageal carcinogenesis. Current Opinion in Pharmacology, 9, 396-404.
    1. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: A double-edged sword. Nature Reviews Immunology, 3, 745-756.
    1. Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009). Targeting inflammatory pathways for prevention and therapy of cancer: Short-term friend, long-term foe. Clinical Cancer Research, 15, 425-430.
    1. Ahirwar, D. K., Agrahari, A., Mandhani, A., & Mittal, R. D. (2009). Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy. Biomarkers, 14, 213-218.
    1. Al-Biaty, H. S. J. (2018). Urinary IL-8 and BLCA-4 in detection of bladder cancer and their clinical significant. Iraqi Journal of Cancer and Medical Genetics, 8, 31-45.

LinkOut - more resources